Cite
PD34-01 PROSPECTIVE STUDY OF THE RELATIONSHIP BETWEEN CLINICAL OUTCOMES OF ENZALUTAMIDE AND SERUM ANDROGEN LEVELS MEASURED BY LC-MS/MS IN CRPC PATIENTS
MLA
Kazuhiro Suzuki, et al. “Pd34-01 Prospective Study of the Relationship between Clinical Outcomes of Enzalutamide and Serum Androgen Levels Measured by Lc-Ms/Ms in Crpc Patients.” Journal of Urology, vol. 206, Sept. 2021. EBSCOhost, https://doi.org/10.1097/ju.0000000000002038.01.
APA
Kazuhiro Suzuki, Seiji Arai, Yutaka Takezawa, Takeshi Miyao, Daisuke Oka, Tomoyuki Takei, O. Haruyuki, Yoshiyuki Miyazawa, Tetsuya Nakamura, Hiroshi Nakayama, Nobuaki Shimizu, Y. Matsuo, & Yoshitaka Sekine. (2021). Pd34-01 Prospective Study of the Relationship between Clinical Outcomes of Enzalutamide and Serum Androgen Levels Measured by Lc-Ms/Ms in Crpc Patients. Journal of Urology, 206. https://doi.org/10.1097/ju.0000000000002038.01
Chicago
Kazuhiro Suzuki, Seiji Arai, Yutaka Takezawa, Takeshi Miyao, Daisuke Oka, Tomoyuki Takei, O. Haruyuki, et al. 2021. “Pd34-01 Prospective Study of the Relationship between Clinical Outcomes of Enzalutamide and Serum Androgen Levels Measured by Lc-Ms/Ms in Crpc Patients.” Journal of Urology 206 (September). doi:10.1097/ju.0000000000002038.01.